About us

YCharOS follows a gold standard genetic characterization process which uses both a cell line expressing adequate endogenous levels of the target protein and a CRISPR knockout version of the same cell line as a negative control. The applications tested are immunoblot, immunoprecipitation and immunofluorescence.

We are committed to following the open science principles and all our methods and results will be transparent and patent-free.

The antibody characterization methodology follows a seminal methodology formalized at the Montreal Neurological Institute.

The company is wholly-owned by the Agora Open Science Trust, a registered charity.